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The mismatch negativity as an 
index of cognitive decline for the 
early detection of Alzheimer’s 
disease
Manuela Ruzzoli1, Cornelia Pirulli2, Veronica Mazza3, Carlo Miniussi2,3 & Debora Brignani2
Evidence suggests that Alzheimer’s disease (AD) is part of a continuum, characterized by long preclinical 
phases before the onset of clinical symptoms. In several cases, this continuum starts with a syndrome, 
defined as mild cognitive impairment (MCI), in which daily activities are preserved despite the presence 
of cognitive decline. The possibility of having a reliable and sensitive neurophysiological marker 
that can be used for early detection of AD is extremely valuable because of the incidence of this type 
of dementia. In this study, we aimed to investigate the reliability of auditory mismatch negativity 
(aMMN) as a marker of cognitive decline from normal ageing progressing from MCI to AD. We compared 
aMMN elicited in the frontal and temporal locations by duration deviant sounds in short (400 ms) and 
long (4000 ms) inter-trial intervals (ITI) in three groups. We found that at a short ITI, MCI showed only 
the temporal component of aMMN and AD the frontal component compared to healthy elderly who 
presented both. At a longer ITI, aMMN was elicited only in normal ageing subjects at the temporal 
locations. Our study provides empirical evidence for the possibility to adopt aMMN as an index for 
assessing cognitive decline in pathological ageing.
Auditory mismatch negativity (aMMN) is an event-related potential (ERP) component occurring approximately 
100–200 ms after a detectable change (deviant stimulus) in a repetitive and predictive sequence of sounds (stand-
ard stimuli)1. aMMN appears maximal at the central-frontal electrodes with an inversion of polarity at the mas-
toids, which is consistent with neural generators located in the temporo-frontal network2,3. aMMN recorded from 
temporal electrodes is associated with the encoding of the physical features of the stimuli and the maintenance of 
the sensory memory trace; while aMMN recorded from frontal electrodes has been linked to involuntary capture 
of attention triggered by the occurrence of the deviant tone4–7. The aMMN elicitation arises from an automatic 
comparison between the deviant sensory input and the sensory-memory trace representing the preceding stim-
uli8. MMN is also considered an index of the efficiency of the auditory system to extract regularities in a sequence 
of sounds and to detect abnormalities based on predictions, according to the predictive coding theoretical frame-
work9. aMMN is commonly used in clinical settings for indexing (i) auditory discrimination accuracy, (ii) sen-
sory–memory duration5, and (iii) general cognitive decline10.
Recording aMMN at different inter-stimulus intervals (ISI) (typically, short ISI are less than 500 ms, whereas 
long ISI are more than 2 sec) is an experimental modulation used to investigate the accuracy of sensory memory 
encoding (short ISI) and the integrity of maintenance of sensory information (long ISI). By gradually extending 
ISI, the aMMN eventually vanishes, which enables one to assess sensory-memory duration. It has been found that 
in healthy participants, acoustic memory decays after a few seconds because aMMN is no longer elicited if the ISI 
is longer than 10 seconds11,12.
Because aMMN is elicited in the absence of direct control of voluntary attention, it is considered an auto-
matic orienting towards salient events, and for this reason, it is particularly useful for the investigation of clinical 
populations in which prolonged sustained attention tasks are difficult to perform. Interestingly, Näätänen and 
colleagues have recently proposed MMN as an index of the cognitive decline occurring in a large number of 
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different neurological and neuropsychiatric diseases10,13,14. Irrespective of their different aetiologies and symp-
tomatologies, most of these disabilities share a functional deficiency of the auditory-frontal cortex network of 
auditory discrimination.
AD is a neurodegenerative and progressive dementia characterized by a gradual cognitive decline, principally 
affecting memory and other cognitive abilities, such as attention, language and executive functions15. In addition, 
with disease progression, behavioural symptoms such as delusions and agitation, and changes in personality or 
mood disturbances may also occur16. At the pathogenetic level, the core hallmarks of AD are the accumulation of 
beta-amyloid plaques and neurofibrillary tangles, which are associated with neuronal loss, synaptic loss and brain 
atrophy (for a review17,18). Therefore, AD dementia is considered part of a concoction of clinical and biological 
phenomena.
Many studies support the presence of a long preclinical phase of AD, estimated to begin decades before any 
clinical symptoms occur19–21. In fact, mild cognitive impairment (MCI) is a clinical syndrome characterized by 
objective cognitive decline with overall preserved everyday activities22. According to the symptomatology, two 
principal subtypes of MCI patients are identified: amnestic MCI (aMCI), in which memory appears to be promi-
nently impaired23,24, and non-amnestic MCI, in which there are mild cognitive deficits in several domains without 
memory component (e.g., visuospatial skills, attention, language). aMCI has long been considered a prodromal 
phase of AD23,25, as clinical and longitudinal evidence indicates that a large portion of patients diagnosed with 
aMCI subsequently develop AD26,27. AD poses a tremendous socioeconomic burden on families and on national 
health systems worldwide. Several experiments are currently underway, investigating effective interventions in 
people with MCI that would enable practitioners to intervene early in the trajectory of the disease and thus slow 
down or even halt progression to AD. For this reason, it could be crucial to identify a reliable clinical marker for 
an early diagnosis of the disease (e.g. ref. 28). Modifications of aMMN latency or amplitude across MCI and AD 
patients may be an ideal marker to evaluate a functional impairment of the fronto-temporal network in the con-
tinuum of a disease affecting primarily memory.
The literature is quite consistent in suggesting that the mechanisms responsible for the automatic detection of 
deviant stimuli and for the memory-trace formation are preserved in AD patients in the auditory29–31 and visual 
domain (considering the visual counterpart to MMN (vMMN)32,33. The memory traces, however, decay faster in 
AD patients compared to age-matched healthy subjects, as revealed in a study by Pekkonen and colleagues34, in 
which a smaller aMMN amplitude was reported at 3 s of ISI. To our knowledge, no other studies have explored 
aMMN in AD patients at longer ISI as index of pathologically shortened sensory memory duration.
On the other hand, the existing evidence on aMCI patients is contradictory, principally due to the scarcity 
of studies and the more heterogeneous manifestations of the disease. To date, only two studies have evaluated 
aMMN in aMCI patients35,36. Mowszowski and colleagues35 presented binaural pure tones at a 500 ms stimulus 
onset asynchrony and found reduced aMMN amplitude over the temporal areas in the aMCI group compared 
to the healthy control group. These results were considered to reflect an impairment of the early stages of the 
information processing. Lindìn and colleagues36 used a more complex auditory-visual attention-distraction task, 
in which the interval between auditory stimuli was 2.35 s. They did not found any significant difference between 
aMCI patients and healthy control subjects when comparing the aMMN elicited by standard (i.e., tone bursts, 
1000 Hz) and deviant (i.e., tone bursts, 2000 Hz) stimuli. However, they did observe significantly smaller aMMN 
amplitude in the aMCI than in the control subjects when comparing standard tones with novel stimuli (different 
each time: glass crashing, ringing, etc.). This effect was reported only for the middle-aged subgroup (between 50 
and 64 years of age) while no difference in the aMMN amplitude was found for adults 65 years and older. This 
data, although hard to interpret, may suggest some sort of weakening of echoic memory trace in aMCI patients.
In our study, we evaluated, by means of aMMN, the potential alterations of auditory sensory memory in AD 
and aMCI patients compared to a control group of normal elderly subjects. We used a fast paradigm37,38 that 
reduces the recording time compared to the classic paradigm by about one-third, suited perfectly to our purpose 
of testing clinical populations. To identify possible differences between groups in encoding acoustic stimuli and/
or in maintaining the representation of such stimuli over time, we compared the aMMN elicited at short vs. 
long inter-trial intervals (ITI, 400 vs. 4000 ms; it should be noted that in the present paradigm, the ITI definition 
overlaps with the classical ISI definition). Based on the previous evidence, we expected to observe aMMN in AD 
patients at short, but not at long ITI, as 4000 ms should exceed their sensory-memory duration. Crucially, aMCI 
patients, who are commonly considered to be midway between normal ageing and dementia, could already show 
an abnormal aMMN component similarly to AD patients. This would allow discriminating normal and patho-
logical ageing in the early phases.
Methods
Participants. In total, 18 healthy elderly people, 12 aMCI patients and 19 AD patients took part in the exper-
iment. Data from healthy participants of a previous experiment (see ref. 38) were used as control. Patients were 
recruited in the outpatient facility of the National Institute for the Research and Care of Alzheimer’s disease at 
the IRCCS Centro San Giovanni di Dio Fatebenefratelli (Brescia, Italy). The clinical diagnosis of aMCI or AD 
followed the standard clinical criteria26,39 and was based upon a complete neurological, neuropsychological and 
neuroimaging assessment.
Inclusion criteria was comprised of the following: (i) a Mini Mental State Examination score (MMSE) > 24 
(corrected for age and level of education) for healthy elderly and aMCI patients40 and (ii) MMSE < 24 and a stable 
dose of a cholinesterase inhibitor for at least six months prior to the onset of the study for AD patients. Exclusion 
criteria, instead, included evidence of significant medical illness or substance abuse that could impair cognitive 
functioning and any other major systemic, psychiatric or neurological illnesses. Furthermore, a brief hearing test 
was performed prior to the EEG recording to exclude subjects who presented peripheral sensory deficit.
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All participants were submitted to a neuropsychological evaluation to assess the global cognitive functioning 
(MMSE), language comprehension (Token Test), memory (Digit Span; Spatial Span, Rey-Osterrieth Complex 
Figure- Recall, Rey Auditory Verbal Learning Test -Immediate and Delayed), constructional and visuo-spatial 
abilities (Rey-Osterrieth Complex Figure - Copy), attention and executive functions (Trail-Making Test A and B) 
(see table 1). All tests were administered and scored by neuropsychological professionals according to standard 
procedures41. Healthy elderly people who presented one or more pathological test scores were excluded from the 
study.
EEG recordings heavily compromised by muscular artefacts and/or eye movements were excluded from the 
analysis. The final composition of the groups was therefore as follows: 12 healthy elderly (7 males, mean age 
69 ± 5.51 years), 8 aMCI (4 males, mean age 68 ± 6.27 years) and 12 AD (6 males, mean age 72 ± 4.49 years). The 
groups were matched for age (F (2, 29) = 2.303, p = 0.1) and education (F (2, 29) = 0.774, p = 0.5).
Written informed consent was obtained from all participants or from their caregivers prior to the beginning of 
the experiment. All experimental protocols were performed in accordance with the Code of Ethics of the World 
Medical Association. The experiment was approved by the Ethics Committee for research in human subjects of 
the IRCCS San Giovanni di Dio Fatebenefratelli, Brescia.
Stimuli and Procedure. The stimuli and procedures were the same as those used in Grau et al.37 and rep-
licated in Ruzzoli et al.38 (see Fig. 1). Sequences of three tones (train of tones) were presented binaurally with 
earphones. The sequences differed only for the first tone, which could be standard (50%) or deviant (50%). All the 
remaining tones were standard. The standard tone was a pure sine-wave tone of 700 Hz, with an intensity of 85 dB 
SPL (Sound Pressure Level) and a duration of 75 ms. The deviant tone had the same frequency and intensity as the 
standard tone but a different duration (i.e., 25 ms). The interval within the train of stimuli was 300 ms.
Each participant completed two separate experimental sessions in which different short (400 ms) or long 
(4000 ms) ITI were used. The order of presentation of the sessions was balanced across participants. In each ses-
sion, 200 standard and 200 deviant trains of stimuli were randomly delivered. The 400-ITI and 4000-ITI sessions 
had a length of 7 and 32 minutes, respectively, including short pauses.
After positioning the EEG cap and earphones, participants sat in a comfortable chair in a dimly illuminated 
room. During the EEG recording, each subject was instructed to watch a silent film without subtitles, to ignore 
the auditory stimuli and to avoid extra eye movements and blinking.
EEG recording and data processing. EEG signal was recorded from 19 electrodes set in an elastic cap 
(Electro-Cap International, Inc.), positioned according to the 10–20 International system (AEEGS, 1991). The 
electrode locations were Fp1, Fp2, F7, F3, Fz, F4, F8, T7, C3, Cz, C4, T8, P7, P3, Pz, P4, P8, O1, and O2. EEG 
signal was also recorded from left and right mastoids (M1, M2). Fpz was used as ground. The reference electrode 








Gender, m/f 7/5 4/4 6/6 — ns ns ns
Age, years 68.8 ± 5.5 68.1 ± 6.3 72.7 ± 4.5 — ns ns ns
Education, years 9.5 ± 4.3 7.5 ± 2.7 7.7 ± 4.9 — ns ns ns
Screening for Dementia
MMSE 27.0 ± 1.8 26.4 ± 1.4 18 ± 4.9 24 ns p < 0.01 p < 0.01
Language Comprehension
Token Test 33.7 ± 2.0 31.28 ± 1.4 25.8 ± 3.8 26.5 ns p < 0.01 p < 0.01
Memory
Digit Span 7.5 ± 5.8 5.6 ± 0.9 4.5 ± 1.1 3.75 ns ns ns
Spatial Span 5.5 ± 0.8 4.3 ± 0.4 4.1 ± 1.5 3.55 p < 0.05 p < 0.01 ns








9.9 ± 2.8 11.9 ± 8.8 4.5 ± 3.1 4.69 ns ns ns
Constructional and visuo-spatial abilities
Rey Copy 34.3 ± 1.8 25.1 ± 4.9 15.1 ± 11.5 28.87 p < 0.05 p < 0.01 p < 0.05
Attention and Executive functions
Trail-Making 
Test A 24.4 ± 15.4 33.0 ± 10.4 92.4 ± 67.0 93 ns p < 0.05 p < 0.01
Trail-Making 
Test B 58.4 ± 65.7 162.8 ± 76.7 285.8 ± 122.8 282 p < 0.05 p < 0.01 p < 0.05
Table 1. Mean scores ( ± standard deviation) for demographic and neuropsychological variables for the 
three groups of participants (healthy elderly, aMCI and AD) and corresponding p-values of between-
groups post-hoc comparisons (ns = non-significant).
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was placed at the tip of the nose. The electro-oculogram (EOG) was recorded from two bipolar channels placed at 
the external side of both eyes for the horizontal EOG and above and below the right eye for the vertical EOG. Data 
were collected with a high cut-off filter of 80 Hz and digitalized at a sampling rate of 250 Hz (BrainAmp MRplus, 
BrainProducts GmbH, Munich, Germany). The impedance was kept below 5 kΩ.
Event-related potentials were obtained offline. The EEG recordings were filtered with a pass-band filter of 
0.1–30 Hz and then divided into epochs, synchronized with the first tone of each sequence (standard or deviant). 
Each epoch was 500 ms in length, including 100 ms pre-stimulus baseline. Trials with eye movements, blinks and 
muscle artefacts were excluded from analysis, as well as trials in which the voltage exceeded ±75 μ V at Fp1/2, Fz, 
F3/4, F7/8, Cz, C3/4, T7/8 and M1/2 locations. Average responses to deviant and standard tones were computed 
separately for each subject and for each ITI (400, 4000 ms). The responses to the last two tones, of each sequence 
of stimuli (both standard tones), were not analysed.
aMMN Analysis. The MMN component was quantified by measuring mean amplitude of responses evoked 
by standard and deviant tones in the 150–180 ms time window. This temporal interval was estimated by visual 
inspection of the temporal window where aMMN occurred in the grand-average waveforms of each group and 
ITI condition, separately. Four electrode locations were considered for the analyses, which were considered as 
frontal (F3, F4) and temporal (M1, M2) aMMN components. Importantly, we expected an enhanced negativity to 
the deviant tone relative to the standard tone over the frontal site and the inversion of polarity over the temporal 
sites, as previously reported in the literature (Giard et al. 1995; Sams et al.11).
Mean amplitudes were analysed with a repetitive measures ANOVA with Group (Elderly, aMCI and AD) 
as between-subjects factor and Tone (standard, deviant), ITI (400 ms, 4000 ms), Area (frontal, temporal) and 
Hemisphere (left, right) as within-subjects factors. Considering the inversion of polarity between frontal and 
temporal areas, the presence of the aMMN component in the analysis should be reflected by the interaction 
between Tone and Area factors, or in their interaction with other factors. The Greenhouse-Geisser method was 
applied when appropriated.
Correlation between aMMN and cognitive functioning (neuropsychological variables). In order 
to highlight possible relations between aMMN and neuropsychological performance, we performed Pearson cor-
relation coefficient analyses considering the amplitude of aMMN at 400 ITI (separately for frontal and tempo-
ral areas) and the neuropsychological test scores (MMSE, Token Test, Digit Span; Spatial Span, Rey Auditory 
Verbal Learning Test Immediate, Rey-Osterrieth Complex Figure- Recall, Rey-Osterrieth Complex Figure-Copy, 
Trail-Making Test A and B) in all the participants. All contrasts were two tailed and employed an alpha level of 
0.05.
Results
aMMN. Figure 2 shows the ERP to the standard and deviant tones and the corresponding topographical maps 
of the difference waves (i.e., aMMN) for healthy elderly, aMCI and AD group, separately. aMMN was evoked in 
frontal areas and in temporal regions (reversed polarity) as showed by the significant interactions Tone x Area 
(F (1, 29) = 36.15, p < 0.001). The interaction ITI x Tone x Area (F (1, 29) = 36.14, p < 0.001) suggested that 
the presence of aMMN was affected by the ITI factor. To better understand this effect, we performed repetitive 
measures ANOVAs with Group (elderly, aMCI and AD), Tone (standard, deviant), Area (frontal, temporal) and 
Hemisphere (left, right) separately for each ITI condition. The ANOVA on 400-ITI condition showed a highly 
significant Tone x Area interaction (F (1, 29) = 59.57, p < 0.001). Subsequent post-hoc analysis, corrected with 
Tukey’s HSD test, revealed a significant difference between standard and deviant tones (i.e., aMMN) in both fron-
tal (p < 0.001) and temporal location (p < 0.001). Also the ANOVA on 4000-ITI condition indicated a significant 
Tone x Area interaction (F (1, 29) = 10.12, p = 0.003), but subsequent post-hoc analysis proved the presence of 
the aMMN in temporal (p = 0.013), but not in frontal (p = 0.48) areas.
The interaction ITI x Tone x Area x Group, which approached significance (F (1, 29) = 2.66, p = 0.08), indi-
cated that this pattern could be different across the groups. With the aim of understanding in which areas and ISIs 
the aMMN emerged as difference between standard and deviant tones in every group, we performed subsequent 
repetitive measures ANOVAs separately for each group, with Tone (standard, deviant), ITI (400 ms, 4000 ms), 
Area (frontal, temporal) and Hemisphere (left, right) as factors. The ANOVA on healthy elderly showed significant 
Figure 1. Schematic representation of auditory MMN paradigm. In total, 400 sequences (200 standard trains 
and 200 deviant trains) of 3 tones were presented randomly. The sequences differed only for the first tone, which 
could be standard (S = 75 ms, thick lines) or deviant (D = 25 ms, thin lines). The SOA between tones within the 
same train was 300 ms. The ITI between the beginning of the last tone of the previous train and the beginning of 
the next tone could be 400 (short) or 4000 ms (long) depending on the condition.
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interaction Tone x Area (F (1, 11) = 25.06, p < 0.001) and ITI x Tone x Area (F (1, 11) = 39.59, p < 0.001), reveal-
ing the presence of aMMN over both frontal (p < 0.001) and temporal (p < 0.001) areas in the 400-ITI condition, 
and a temporal (p = 0.02), but not frontal (p = 0.21), aMMN in the 4000-ITI condition. The ANOVA on MCI 
patients disclosed the same significant interactions as in healthy elderly [Tone x Area (F (1, 7) = 6.18, p = 0.04) 
and ITI x Tone x Area (F (1, 7) = 5.72, p = 0.048)], but post-hoc comparisons revealed the presence of the aMMN 
only in temporal areas (p = 0.020) in the 400-ITI condition (p > 0.1 in all the other comparisons). Similar results 
were found in the ANOVA on AD patients [Tone x Area (F (1, 11) = 10.30, p = 0.008) and ITI x Tone x Area 
(F (1, 11) = 5.78, p = 0.035)], who however showed a significant difference between standard and deviant tones 
only in frontal areas (p = 0.001) during the 400-ITI condition (p > 0.1 in all the other comparisons). To evaluate 
possible differences in the mean amplitude of aMMN across the groups, we compared directly the difference 
waves between standard and deviant tones (i.e., aMMN) only in the areas and ITI where the aMMN was actually 
present (i.e., healthy elderly vs. AD patients in the frontal areas at 400-ITI; healthy elderly vs. MCI patients in the 
temporal areas at 400-ITI). No significant group effects concerning aMMN amplitude emerged (all p’s > 0.7).
Finally, the main ANOVA showed the significant interaction Tone x Area x Hemisphere (F (1, 29) = 8.40, 
p = 0.007), which also interacted with Group (F (1, 29) = 3.33, p = 0.049). Subsequent post-hoc analysis, cor-
rected with Tukey’s HSD test, revealed that, independently by the ITI, healthy elderly and AD groups showed a 
frontal and temporal aMMN both in the left and in the right hemispheres, while the aMCI group showed aMMN 
only in the right hemisphere (frontal and temporal areas).
Figure 2. ERP to the standard and deviant tones and topographical maps of aMMN. At the top: grand-
averaged waveforms elicited by standard (black) and deviant (red) tones in healthy elderly participants, aMCI 
and AD patients. On the left: 400 ITI condition; on the right: 4000 ITI condition. The grand-average response 
from the two electrodes F4 and M2 of the right hemisphere is reported for illustrative purposes. At the bottom: 
scalp topographies of the aMMN amplitude in the 150–180 ms time window for the three groups. The maps 
show the aMMN localized on the right and left side of the scalp for both ITI conditions. In the middle, analysed 
electrodes are represented in red.
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Neuropsychological Test. Neuropsychological test scores were corrected for age and education. The groups 
significantly differed in the scoring of MMSE (F(2, 29) = 25.44, p < 0.001), Spatial Span (F (2, 27) = 5.51, p < 0.01), 
Token test (F (2, 28) = 24.86, p < 0.001), Rey-Osterrieth Complex Figure- Copy (F (2, 27) = 17.8, p < 0.001) and 
Recall (F (2, 26) = 18.73, p < 0.001), and Trial-Making Test A (F (2, 23) = 8.25, p < 0.005) and B (F (2, 20) = 12.58, 
p < 0.001). Post hoc comparisons are highlighted in Table 1. Please note that the scoring of some tests is missing 
for some patients who were unable to complete the entire neuropsychological evaluation. Figure 3 shows corre-
lations between aMMN amplitude and neuropsychological test scores (where present) for healthy elderly, aMCI 
and AD participants at 400-ITI condition only. We did not perform the correlation analysis for the 4000-ITI con-
dition because aMMN was present only in healthy elderly in temporal location. As reported in Table 2, the results 
showed a significant correlation between frontal aMMN and Trail Making Test B (n = 23, r = 0.531 p = 0.01) 
and between temporal aMMN and Rey Auditory Verbal Learning Test Delayed (n = 22, r = 0.465 p = 0.03). For 
completeness, we also reported statistical tendencies in the correlation between frontal aMMN and Token Test 
(n = 31, r = − 0.319 p = 0.08) and between temporal aMMN and Digit Span scores (n = 31, r = 0.336 p = 0.07).
Discussion
In this study, we analysed the frontal and temporal aMMN components elicited by duration deviant sounds in 
two different inter-train intervals (ITI: 400 vs. 4000 ms). We compared data from three groups of participants: 
healthy elderly, aMCI and AD patients. The primary aim was to provide empirical evidence for testing the strate-
gic possibility to adopt aMMN as a parametric index able to characterize the progression of memory impairment 
from normal ageing to AD.
Figure 3. Correlation between aMMN amplitude and neuropsychological tests. (a) Scatterplot correlation 
between frontal aMMN amplitude (y-axis, in μ V) and the Trail Making Test-B score (x-axis, in seconds). 
(b) Scatterplot correlation between temporal aMMN amplitude (y-axis, in μ V) and the Rey Auditory Verbal 
Learning Test (RAVLT) score (x-axis, number of items recalled).
MMN - ITI 400
Frontal MMN Temporal MMN
r p-value r p-value
MMSE − 0.047 0.79 0.136 0.46
Token Test − 0.319 0.08 0.188 0.31
Digit Span − 0.206 0.27 0.336 0.07
Spatial Span − 0.194 0.30 0.080 0.67








− 0.137 0.54 0.465 0.03
Rey Copy − 0.082 0.66 0.179 0.34
Trial-Making 
Test A − 0.013 0.95 − 0.094 0.65
Trial-Making 
Test B 0.531 0.01 − 0.273 0.21
Table 2.  Pearson’s correlation coefficients (r) and associated p-values between aMMN amplitude (frontal 
and temporal) and neuropsychological test scores for healthy elderly, aMCI and AD participants at 400-ITI 
condition. Significant values are in bold.
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Our results showed interesting dissociations between the three populations of participants. In fact, at the short 
ITI (400 ms), AD patients showed a frontal but not temporal aMMN, whereas aMCI patients showed a temporal, 
but not a frontal, aMMN, in comparison to healthy elderly, who showed aMMN in both the frontal and temporal 
areas. At 4000 ms ITI, aMMN was recorded only in the control group at the temporal area. When aMMN was 
present in two groups in the same conditions (healthy elderly and AD patients: frontal areas at 400-ITI; healthy 
elderly and MCI patients: temporal areas at 400-ITI) it showed the same amplitude across the groups.
Our results partially contradict previous evidence showing that early stages of sensory memory were not 
affected by dementia when short intervals between stimuli (from 500 to 2000 ms) are adopted29–33,42. It should 
be noted that most of the studies on aMMN focused on pitch change discrimination, while the present one 
investigated aMMN elicited by duration deviant sounds. The literature on aMMN in normal ageing suggests 
separate cortical generators for aMMN to pitch and duration deviants4,5. Several studies consistently found a 
preserved aMMN to pitch changes but a reduced aMMN to duration deviants7,43–45 in healthy older individuals. 
The only two studies, which investigated aMMN to duration deviance in AD43,46 and in non-specified dementia47, 
actually found an unaffected aMMN compared with normal ageing. However, more investigations are needed to 
definitively exclude that aMMN elicited by pitch and duration changes are differently compromised in dementia 
patients.
In our study, we dissociate between the frontal and temporal components of aMMN. Even if there is not a 
clear relationship between an electrical field observed on the scalp and the brain regions giving rise to that field48, 
consistent evidence suggested different neural generators for the two inverted-polarity aMMN subcomponents. 
Specifically, aMMN recorded at temporal electrodes arises from neural sources localized in the supratemporal 
cortex, while MMN obtained at frontal electrodes reflects activity from the inferior frontal cortex5,8,49–55. The 
temporal component of aMMN is associated with sensory memory encoding (short ITI) and the maintenance of 
sensory information (long ITI)8. The frontal component has been linked to attentional aspects of change detec-
tion5,51 and more specifically, to the efficiency of the auditory system to extract regularities and to detect abnor-
malities based on predictions9. Garrido et al.9 proposed the predictive coding framework to interpret MMN 
that combines the change-detection4,5, the adaptation hypothesis7 and the model-adjustment hypothesis56 in a 
probabilistic perspective of perceptual optimization. The authors suggested that auditory perception is based on 
hierarchically and reciprocally organized neural systems, where the abstractions from higher cortical areas (i.e., 
frontal) should be matched with the data from the lower cortical areas (i.e., temporal) through backward con-
nections. At the same time, through forward connections and prediction error signals, lower cortical structures 
try to adjust the predictions from higher cortical areas based on the actual data. This mechanism lasts until the 
prediction error signal is negligible and the abstractions from higher cortical areas are optimized9,57. Most of 
the studies reporting that automatic discrimination of auditory changes is not affected in AD patients evaluated 
only the frontal aMMN29,30,34. In line with these results, in the present study, AD patients showed that the frontal 
aMMN was comparable to healthy elderly, suggesting a preserved predictive coding system. aMMN, however, was 
absent over the temporal areas in the AD group.
AD has been defined as a disconnection syndrome58,59. Indeed, amyloid accumulation is followed by altera-
tions in resting state functional connectivity at first and then by cortical atrophy60. Several large-scale neural net-
works have been explored in AD, providing evidence for a widespread reduction of both intra- and inter-network 
connectivity, which worsened as AD severity increased61. The default mode network (DMN), the most active 
network in absence of task demand, has been extensively studied in AD27, showing that several regions of the 
DMN are among the earliest to show abnormal amyloid deposition62–64. The DMN includes frontoparietal mid-
line structures, parts of lateral temporal and parietal cortices, and the medial temporal cortex65,66. The evidence 
reported above suggests that the supratemporal cortex, which is the area where the neural generator of the tempo-
ral component of aMMN has been localized, is part of the DMN and shows an abnormal functional connectivity 
with other brain areas in AD patients. Some studies, for instance, have found a decreased connectivity in AD 
patients relative to controls between the superior temporal area (BA 22) and the hippocampus67,68. The passive 
listing paradigm adopted in our paradigm might have been activated the DMN, although participants were not 
in the classic resting-state condition. Consequently, the absence of the aMMN over the temporal areas observed 
in the present study in AD group can be ascribed to the pathological functional connectivity occurring in the 
declared phase of AD. The inferior frontal cortex that generates the frontal component of the aMMN is not part 
of the DMN and consistently, in our data, the frontal aMMN is preserved in AD patients. This result, however, 
is surprising because the frontal aMMN should also be reduced as result of a decreased functional connectiv-
ity between frontal and temporal areas and because substantial evidence of amyloid plaques accumulation has 
been reported in the frontal areas too69–71. Interestingly, Opitz and colleagues49 proposed a specific role of the 
frontal MMN generator in tuning the sensory system according to processing demands. They suggested that the 
activation of a frontal contrast enhancement system increases with decreasing distinctiveness of sound input. 
Accordingly, the presence of the frontal aMMN in AD patients might be ascribed to the low functioning of the 
temporal aMMN generator, which has difficulty in discriminating stimuli. Increased recruitment of the prefrontal 
regions in AD patients has been observed during memory task performance and has been suggested as a not task 
specific compensatory mechanism that reflects a general adaptation to loss of cognitive resources61,72.
Overall, what we observed at short ITI in AD patients is that the higher frontal areas are still able to elaborate 
predictions, but the temporal areas fail to manage low level processing. Exactly the opposite effect occurred in 
aMCI patients at short ITI. The sensory memory encoding (temporal aMMN) was preserved, while the frontal 
component was compromised. The pathophysiological alterations of AD begin early in the progression of the 
disease, even in the preclinical phase, before any cognitive symptom appears60. Similar to AD, aMCI patients 
also show patterns of decreased functional connectivity between regions of the DMN73–75. We argue that, given 
the earlier stage of impairment, the supratemporal cortex might still be preserved in aMCI compared to AD 
patients, such that they showed a temporal aMMN component comparable to that recorded in the healthy elderly. 
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Indeed, an hyperactivation over the temporo-parietal and medial temporal regions has been reported in MCI 
patients compared to controls during memory tasks59,76–78. This pattern has been explained as a compensatory 
mechanism acting as cognition begins to be impaired in early AD pathology and diminished with further dis-
ease progression79. According to the contrast enhancement view49, activation of the frontal generator of aMMN 
critically depends on the interaction between superior temporal cortex and inferior frontal cortex. In conditions 
of normal acoustic stimulation, we expect healthy subjects to show a balanced activation of the frontal and tem-
poral generators of aMMN. In AD patients, the low functioning of the temporal generator could be compen-
sated by a hyper-activation of the frontal source. Conversely, in aMCI patients the pattern might reverse by an 
over-activation of the temporal generator, which might explain the absence of the frontal aMMN. Interpreting 
changes of the neural dynamics over the course of AD pathology however, is only speculative. Evidence suggests 
that the progression of the disease is associated with a nonlinear trajectory of activity alterations: decreases in 
activation in some areas are accompanied by evidence of increased neural activity in other regions, hinting at a 
more complex underlying pattern of network level dysregulation rather than simply at a universal reduction in 
network activity61. Due to the lack of investigations on aMMN in aMCI patients, a comparison of our findings 
with the literature is difficult. To date, there is only one study by Mowszowski and colleagues35 that examined 
aMMN generated by duration deviants at short ITI in aMCI population. They found that the aMMN response 
in aMCI was significantly attenuated in the temporal areas compared to healthy elderly, whereas there was no 
significant difference between groups in aMMN amplitude at frontal and central location. The inconsistency of 
findings may be due to the aetiological heterogeneity of aMCI patients. Current evidence, indeed, indicates that 
aMCI can result from AD pathology as well as from other non-AD aetiologies80. Further investigation on aMMN 
should characterize aMCI patients based on their biological profile in order to control for the heterogeneity of 
the sample.
The most relevant contribution of the present study concerns results of aMMN at the long ITI (4000 ms). In a 
previous study38 on changes in auditory sensory memory during physiological ageing, we found that the memory 
trace for the standard stimuli decayed more rapidly in healthy elderly respect to young and middle-aged individ-
uals. At the long ITI, the elderly showed no frontal aMMN and a reduced temporal aMMN. Because the presence 
of the aMMN component is proved by the significant difference between the waves elicited by the standard and 
deviant tones, the temporal aMMN recorded in the healthy elderly reached no significant difference when com-
pared with the larger aMMN generated in young and middle-aged participants38, but it did reach significance 
when compared with the small, if any, aMMN observed in the patients groups. In fact, in the present study, AD 
patients showed no reliable aMMN in any locations when the ITI was 4000 ms, in agreement with the previous 
literature. Pekkonen and colleagues34 found that aMMN in AD group was still present but reduced when using an 
interval of 3000 ms. It is plausible that such temporal interval corresponds to the boundaries of the sensory–mem-
ory duration in AD patients. Accordingly, the stimulus trace could still be present at 3000 ms, although already 
compromised, and it could be definitively decayed at longer temporal intervals. Pekkonen and colleagues34 how-
ever, investigated only the frontal aMMN; we do not know whether the aMMN was detectable at 3000 ms over 
the temporal regions. Consistent with our results concerning the short ITI, we can hypothesize that the aMMN is 
unlikely generated in AD patients over the temporal areas, at least for ITI superior to 400 ms.
Importantly, aMCI patients showed the same aMMN pattern observed in AD patients at long ITI. This means 
that, independent of the different dynamics affecting the encoding phase in the course of the disease, the impair-
ment of echoic memory trace begins early in the progression of AD pathology. Therefore, our data support that 
aMMN investigated over both frontal and temporal areas at long ITI might be a sensitive index useful for an early 
diagnosis of cognitive impairment likely due to AD. This aspect is particularly valuable if we consider that the 
aMMN recording is non-invasive, low-cost and easy to conduct also for non-specialized staff members.
Our results are specific for the aMMN elicited by duration deviants, which has proven to be more sensitive 
than other types of deviants used in other clinical studies81. However, our findings have to be corroborated in 
studies with larger sample sizes. In addition, in order to identify a sensitive paradigm that might be adopted in 
the clinical routine, it is timely that further studies will explore both frontal and temporal aMMN at different ITIs 
ranging between 2000 and 4000 ms. Systematic investigation could reveal the most appropriate parameters, able 
to identify the earliest abnormalities (e.g., preclinical AD) and possibly to discriminate between different clinical 
populations (e.g., AD versus frontotemporal dementia). Moreover, repetitive sessions of aMMN could be a useful 
tool to monitor the progression of the disease and to predict the conversion of aMCI patients to AD. A recent 
study on comatose patients has reported that the deterioration in aMMN between two separate recording sessions 
was the most predictive index of clinical outcome81.
Finally, in line with our main purpose to test the reliability of aMMN as a neurophysiological index for mem-
ory loss progression from healthy elderly to AD, it is also important to underline that aMMN recorded at the 
short ITI correlated with some of the neuropsychological tests’ scores (see Fig. 3). In particular, we found that 
frontal aMMN significantly correlated with Trial Making Test-B. TMT-B82,83 is a neuropsychological test used for 
measuring visual attention and task switching (i.e., executive functions), which are considered frontal functions. 
Taking into account that TMT-B is measured in seconds and frontal aMMN has a negative value, this positive 
correlation showed that the more negative aMMN was, the faster the participants were to complete the test. In 
addition, in our sample, the Rey Auditory Verbal Learning Test (RAVLT) Recall correlated with the temporal 
component of the aMMN. Recall RAVLT is a test used to assess short-term auditory-verbal memory, rate of earn-
ing, learning strategies, retroactive, and proactive interference, presence of confabulation, of confusion in mem-
ory processes, retention of information, and retrieval. Because the score at TMT-B reflects the number of words 
recalled and temporal aMMN has a positive value, this positive correlation showed that the more positive the 
aMMN was, the better the performance at RAVLT. This evidence, although correlative, support the importance 
of the frontal and temporal aMMN as sensitive indices for evaluating frontal executive functions and memory 
integrity, respectively, in normal and pathological ageing.
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In conclusion, our data supports the proposal by Nätäänen and colleagues14,84 that aMMN is a valuable index 
for assessing general cognitive decline in different neurological and psychiatric pathologies. Our data provide 
empirical evidence for the possibility to adopt aMMN in clinical settings as an index for memory decay in aMCI 
and AD patients and more generally in pathological ageing.
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